{"entity":{"type":"insider","cik":"0001792987","url":"/insider/0001792987","json_url":"/insider/0001792987.json","name":"Ferrara Robert L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2021-03-03","last":"2025-06-11","span_basis":"filed_date"},"name_variants":[{"name":"Ferrara Robert L","source":"filing","n_filings":6,"first_seen":"2021-03-03","last_seen":"2025-06-11"}],"transactions":[{"id":4247682,"accession":"0001062993-25-011423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-011423","line_url":"/filing/0001062993-25-011423#line-1","is_derivative":false,"issuer_cik":"0001533040","issuer_name":"Phio Pharmaceuticals Corp.","issuer_ticker":"PHIO","issuer_name_source":null,"issuer_url":"/issuer/0001533040","owner_cik":"0001792987","owner_name":"Ferrara Robert L","owner_display_name":"Ferrara Robert L","owner_url":"/insider/0001792987","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.4199,"price_display":"2.42","price_state":"stated","total_value":6049.75,"total_display":"6,049.75","total_whole":"6,050","shares_owned_after":15666.0,"shares_owned_after_display":"15,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-11","scope":"insider"},{"id":4628611,"accession":"0001062993-25-009985","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-009985","line_url":"/filing/0001062993-25-009985#line-1","is_derivative":false,"issuer_cik":"0001533040","issuer_name":"Phio Pharmaceuticals Corp.","issuer_ticker":"PHIO","issuer_name_source":null,"issuer_url":"/issuer/0001533040","owner_cik":"0001792987","owner_name":"Ferrara Robert L","owner_display_name":"Ferrara Robert L","owner_url":"/insider/0001792987","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":4550.0,"total_display":"4,550.00","total_whole":"4,550","shares_owned_after":13166.0,"shares_owned_after_display":"13,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-21","scope":"insider"},{"id":8752421,"accession":"0001209191-23-037408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037408","line_url":"/filing/0001209191-23-037408#line-1","is_derivative":false,"issuer_cik":"0001533040","issuer_name":"Phio Pharmaceuticals Corp.","issuer_ticker":"PHIO","issuer_name_source":null,"issuer_url":"/issuer/0001533040","owner_cik":"0001792987","owner_name":"Ferrara Robert L","owner_display_name":"Ferrara Robert L","owner_url":"/insider/0001792987","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":6200.0,"total_display":"6,200.00","total_whole":"6,200","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider"},{"id":6988411,"accession":"0001209191-22-059702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-059702","line_url":"/filing/0001209191-22-059702#line-1","is_derivative":false,"issuer_cik":"0001533040","issuer_name":"Phio Pharmaceuticals Corp.","issuer_ticker":"PHIO","issuer_name_source":null,"issuer_url":"/issuer/0001533040","owner_cik":"0001792987","owner_name":"Ferrara Robert L","owner_display_name":"Ferrara Robert L","owner_url":"/insider/0001792987","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.4082,"price_display":"0.41","price_state":"stated","total_value":2041.0,"total_display":"2,041.00","total_whole":"2,041","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-05","scope":"insider"},{"id":6754471,"accession":"0001209191-22-058862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058862","line_url":"/filing/0001209191-22-058862#line-1","is_derivative":false,"issuer_cik":"0001533040","issuer_name":"Phio Pharmaceuticals Corp.","issuer_ticker":"PHIO","issuer_name_source":null,"issuer_url":"/issuer/0001533040","owner_cik":"0001792987","owner_name":"Ferrara Robert L","owner_display_name":"Ferrara Robert L","owner_url":"/insider/0001792987","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.4099,"price_display":"0.41","price_state":"stated","total_value":819.8,"total_display":"819.80","total_whole":"820","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-28","scope":"insider"},{"id":4555073,"accession":"0001209191-21-017572","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017572","line_url":"/filing/0001209191-21-017572#line-2","is_derivative":false,"issuer_cik":"0001533040","issuer_name":"Phio Pharmaceuticals Corp.","issuer_ticker":"PHIO","issuer_name_source":null,"issuer_url":"/issuer/0001533040","owner_cik":"0001792987","owner_name":"Ferrara Robert L","owner_display_name":"Ferrara Robert L","owner_url":"/insider/0001792987","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":682.0,"shares_display":"682","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":2148.3,"total_display":"2,148.30","total_whole":"2,148","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001533040","name":"Phio Pharmaceuticals Corp.","url":"/issuer/0001533040","role":"Director","n_filings":6,"first_seen":"2021-03-03","last_seen":"2025-06-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001792987","retrieved_at":"2026-08-22T15:13:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}